Supplement use in the adolescent athlete.
Use of dietary supplements has become common practice among adolescent athletes in the United States. Concern has arisen regarding safety in adolescents in light of the fact that supplements are not required to meet usual US Food and Drug Administration requirements for standard pharmaceuticals. Furthermore, advertised ergogenic gains are based on little or no scientific evidence. Creatine, anabolic steroids, androstenedione, dehydroepiandrosterone, caffeine, ephedrine-type alkaloids, calcium beta-hydroxy-beta-methybutyrate, and human growth hormone are reviewed. Although some studies have indicated performance benefit in particular athletic situations, there are few available data in adolescents. Furthermore, the few safety studies of these supplements do not include adolescents. Adolescents may be at particular risk when using anabolic steroids and caffeine-ephedra combinations. Research has demonstrated effective education programs can reduce adolescents' intentions to use dietary supplements.
DesJardins
Matt
M
The University of Utah, The Orthopedic Specialty Hospital, 5848 South 300 East, Salt Lake City, UT 84107, USA. mtdmd@hotmail.com
D000293:Adolescent; D018663:Adrenergic Agents / Q000008:administration & dosage / Q000009:adverse effects; D000470:Alkaloids / Q000008:administration & dosage / Q000009:adverse effects; D045930:Anabolic Agents / Q000008:administration & dosage / Q000009:adverse effects; D002110:Caffeine / Q000008:administration & dosage / Q000009:adverse effects; D002118:Calcium / Q000008:administration & dosage / Q000009:adverse effects; D000697:Central Nervous System Stimulants / Q000008:administration & dosage / Q000009:adverse effects; D003401:Creatine / Q000008:administration & dosage / Q000009:adverse effects; D019587:Dietary Supplements / Q000009:adverse effects*; D004300:Doping in Sports; D004809:Ephedrine / Q000008:administration & dosage / Q000009:adverse effects; D019382:Human Growth Hormone / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D014631:Valerates / Q000008:administration & dosage / Q000009:adverse effects
D018663:Adrenergic Agents; D000470:Alkaloids; D045930:Anabolic Agents; D000697:Central Nervous System Stimulants; D014631:Valerates; D019382:Human Growth Hormone; C004961:beta-hydroxyisovaleric acid; D002110:Caffeine; D004809:Ephedrine; D003401:Creatine; D002118:Calcium